| pH | Primary Process |
|---|---|
| < 7.35 | Acidemia (acidosis is the dominant process) |
| 7.35โ7.45 | Normal (or mixed disorder with complete compensation) |
| > 7.45 | Alkalemia (alkalosis is the dominant process) |
| If pH < 7.35 (acidemia) | If pH > 7.45 (alkalemia) |
|---|---|
| PCOโ > 40 โ respiratory acidosis (hypoventilation) | PCOโ < 40 โ respiratory alkalosis (hyperventilation) |
| HCOโ < 22 โ metabolic acidosis | HCOโ > 26 โ metabolic alkalosis |
| Primary Disorder | Expected Compensation |
|---|---|
| Metabolic acidosis | Winter's formula: expected PCOโ = 1.5 ร [HCOโ] + 8 (ยฑ 2). If actual PCOโ โ expected โ additional respiratory disorder. |
| Metabolic alkalosis | Expected PCOโ = 0.7 ร [HCOโ] + 21 (ยฑ 2). Or: PCOโ rises ~0.7 for each 1 mEq/L rise in HCOโ. |
| Acute respiratory acidosis | HCOโ rises 1 per 10 mmHg โ PCOโ |
| Chronic respiratory acidosis | HCOโ rises 3.5 per 10 mmHg โ PCOโ |
| Acute respiratory alkalosis | HCOโ falls 2 per 10 mmHg โ PCOโ |
| Chronic respiratory alkalosis | HCOโ falls 5 per 10 mmHg โ PCOโ |
| Cause | Mechanism |
|---|---|
| M ethanol | Alcohol dehydrogenase converts methanol to formic acid, which inhibits cytochrome oxidase and damages the retina (optic disc edema, blindness). Treat with fomepizole + dialysis. |
| U remia | Failing kidneys cannot excrete sulfates, phosphates, urate, and other organic anions. Develops at GFR < 20. |
| D KA (also alcoholic KA, starvation KA) | Insulin deficiency (or alcohol-induced NADH excess) drives lipolysis and hepatic ketogenesis. Accumulating β-hydroxybutyrate and acetoacetate are the unmeasured anions. |
| P ropylene glycol | Solvent in IV lorazepam, phenobarbital, and diazepam infusions. Metabolized by alcohol dehydrogenase to lactic acid. Classic iatrogenic ICU cause after high-dose benzo drips. |
| I soniazid / Iron | INH depletes pyridoxine (B6) and inhibits GABA synthesis → refractory seizures + lactic acidosis. Treat with high-dose pyridoxine 1:1 (g per g of INH ingested). Iron OD disrupts mitochondrial oxidative phosphorylation → lactate. |
| L actic acidosis #1 cause in hospital | Type A: tissue hypoperfusion or hypoxia (sepsis, shock, ischemia, severe anemia, CO poisoning). Type B: drugs (metformin, linezolid, propofol, NRTIs, β2 agonists), liver failure, malignancy (Warburg effect), thiamine deficiency, D-lactic from short bowel. See full breakdown in Differentials tab. |
| E thylene glycol | Antifreeze. Metabolized to glycolic acid (AG acidosis) and oxalic acid (calcium oxalate crystalluria → AKI). Treat with fomepizole + dialysis. Bedside clues: oxalate crystals in urine, fluorescence under Wood's lamp (some products). |
| S alicylates | Uncouples mitochondrial oxidative phosphorylation → AG acidosis. Also directly stimulates the medullary respiratory center → early respiratory alkalosis. The classic mixed disorder (AGMA + resp alkalosis) is the giveaway. Tinnitus is the bedside tell. |
| Cause | Mechanism |
|---|---|
| H yperalimentation (TPN) | Cationic amino acids (lysine, arginine, histidine) in TPN generate HCl as they are metabolized. Modern TPN includes acetate buffer to offset this; classic boards still tests it. |
| A ddison's / Acetazolamide | Addison's (adrenal insufficiency): low aldosterone → impaired distal H+ and K+ excretion (mimics Type 4 RTA, hyperK). Acetazolamide: blocks proximal carbonic anhydrase → bicarbonate wasted in urine. |
| R TA | Type 1 (distal): α-intercalated cells cannot secrete H+ → urine pH > 5.5, hypoK, kidney stones (Sjรถgren, SLE). Type 2 (proximal): impaired HCO3- reabsorption → Fanconi syndrome, hypoK. Type 4: hypoaldosteronism (DM, ACEi/ARB, TMP-SMX, heparin, spironolactone) → hyperK. Most common RTA. |
| D iarrhea #1 cause of NAGMA | Direct loss of bicarbonate-rich small bowel and colonic secretions. Urine AG is negative (kidneys appropriately excrete NH4+), distinguishing it from RTA. |
| U reteral diversion (ileal conduit, ureterosigmoidostomy) | Bowel mucosa exchanges urinary Cl- for HCO3-. The longer the urine sits in contact with bowel, the more HCO3- is lost. |
| P ost-hypocapnia / Pancreatic fistula | Post-hypocapnia: chronic respiratory alkalosis caused renal HCO3- wasting as compensation; when PaCO2 abruptly normalizes (e.g., post-intubation), bicarb is now inappropriately low. Pancreatic fistula or biliary drain: direct loss of HCO3-rich secretions. |
| S aline (NS resuscitation) | Large-volume 0.9% NS delivers a Cl- load that displaces HCO3- extracellularly = hyperchloremic dilutional acidosis. Switch to LR or PlasmaLyte for ongoing resuscitation. SMART 2018 |
| Ratio | Interpretation |
|---|---|
| < 1 | AG metabolic acidosis + concurrent non-AG metabolic acidosis (the bicarb dropped more than expected from the AG alone โ additional acid or bicarb loss) |
| 1โ2 | Pure AG metabolic acidosis (the drop in bicarb matches the rise in AG) |
| > 2 | AG metabolic acidosis + concurrent metabolic alkalosis (bicarb is higher than expected โ something is raising it -vomiting, diuretics, bicarb administration) |
| Cause | Mechanism |
|---|---|
| C ontraction (volume depletion) SALINE-RESP | Loss of Clโป-rich extracellular fluid (vomiting, diuretics, sweating) makes the proximal tubule reabsorb Naโบ paired with HCO3- instead of Clโป. Volume contraction also activates RAAS → aldosterone drives distal Hโบ secretion. Together: rising and maintained HCO3-. |
| L icorice (glycyrrhizic acid) SALINE-RESIST | Inhibits renal 11β-HSD2, which normally inactivates cortisol to cortisone in the collecting duct. Unopposed cortisol activates the mineralocorticoid receptor → apparent mineralocorticoid excess (Na retention, Kโบ and Hโบ wasting). Mimics primary hyperaldosteronism but with low renin AND low aldosterone. |
| E ndocrine (Conn's, Cushing's, Bartter, Gitelman) SALINE-RESIST | Conn's: autonomous aldosterone → distal Na/K and Na/H exchange. Cushing's: excess cortisol overwhelms 11β-HSD2. Bartter: defective NKCC2 in TAL = "endogenous loop diuretic" (hypoK, hypoCl, alkalosis, normal BP). Gitelman: defective NCC in DCT = "endogenous thiazide" (adds hypoMg). |
| V omiting / NG suction SALINE-RESP Common | Direct loss of HCl from gastric secretions raises serum HCO3- (every Hโบ lost = one HCO3- generated). Concurrent volume and Clโป depletion add a contraction component, perpetuating the alkalosis until both are repleted. |
| E xcess alkali SALINE-RESP | Direct HCO3- load: IV sodium bicarbonate, milk-alkali syndrome (CaCO3 antacids + milk → hyperCa, AKI, alkalosis; full breakdown in Hypercalcemia topic), massive transfusion (citrate metabolized to bicarb by the liver), TPN with acetate buffer overload. |
| R efeeding SALINE-RESP | Carb load triggers insulin surge → cellular uptake of Kโบ, phos, Mg, and intracellular Hโบ shift. The resulting hypokalemia and intracellular acidosis maintain extracellular alkalosis. Watch closely in malnourished patients restarting nutrition. Full breakdown → Refeeding Syndrome topic. |
| P ost-hypercapnia SALINE-RESP | Chronic respiratory acidosis (COPD) caused renal HCO3- retention as compensation. When PaCO2 abruptly normalizes (post-intubation overventilation, NIV, mechanical hyperventilation), HCO3- is left inappropriately high → unmasked metabolic alkalosis. Avoid by lowering ventilator support gradually. |
| D iuretics (loop, thiazide) RESIST (active) RESP (off) | Block Na/Cl reabsorption proximal to the collecting duct → increased distal Naโบ delivery + secondary hyperaldosteronism → distal Na/K and Na/H exchange. Plus volume contraction, hypoK, and hypoCl. While dosed: urine Cl > 20 (resistant). After stopping: urine Cl falls, becomes responsive. Kโบ-sparing diuretics (spironolactone, eplerenone, amiloride) do NOT cause alkalosis (and can correct it). |
| Urine Clโป | Category | Causes | Treatment |
|---|---|---|---|
| < 20 mEq/L | Chloride-responsive (saline-responsive) | Vomiting/NG suction (#1), diuretics (after stopping), post-hypercapnia | NS (volume + chloride repletion). Correct the deficit. |
| > 20 mEq/L | Chloride-resistant | Hyperaldosteronism (Conn syndrome), Cushing's, Bartter/Gitelman, active diuretic use, severe hypokalemia | Treat underlying cause. Kโบ repletion. Spironolactone if hyperaldosteronism. |
| Type | Defect | pH | Kโบ | Classic Association |
|---|---|---|---|---|
| Type 1 (Distal) | Can't secrete Hโบ in distal tubule | Urine pH > 5.5 (can't acidify) | โ (hypoK) | Sjรถgren, SLE, nephrocalcinosis, amphotericin B |
| Type 2 (Proximal) | Can't reabsorb HCOโ in proximal tubule | Urine pH < 5.5 (once threshold exceeded) | โ (hypoK) | Fanconi syndrome, multiple myeloma, carbonic anhydrase inhibitors (acetazolamide) |
| Type 4 (Hypoaldo) | โ Aldosterone or tubular resistance | Urine pH < 5.5 | โ (hyperK) | Most common RTA. Diabetic nephropathy, ACEi/ARBs, spironolactone, TMP-SMX, heparin |
Cohen-Woods classification. Two types only: A (hypoperfusion) and B (everything else). B is subdivided into B1, B2, B3. Every named cause (MALA, propofol infusion, D-lactic acidosis) sits inside one of these buckets.
| Type | Mechanism | Causes |
|---|---|---|
| Type A Most common | Tissue hypoperfusion or hypoxia. Anaerobic glycolysis surges. | Shock (septic, cardiogenic, hypovolemic, obstructive), regional ischemia (mesenteric, limb, compartment syndrome), severe hypoxemia, severe anemia, CO poisoning, post-arrest, seizures, heavy exertion. |
| Type B1 Underlying disease | Disease impairs lactate clearance or shifts metabolism without overt hypoperfusion. | Liver failure (impaired clearance), malignancy (Warburg effect; classic in leukemia/lymphoma), sepsis (overlaps with A), thiamine deficiency, diabetes, pheochromocytoma, short bowel / SIBO → D-lactic acidosis. |
| Type B2 Drugs / toxins | Mitochondrial toxicity, β2 stimulation, or impaired clearance. | Metformin (MALA, especially with AKI), linezolid (> 2 wks), propofol infusion syndrome, NRTIs (didanosine, stavudine, zidovudine), β2 agonists (albuterol, epinephrine, terbutaline), salicylates, cyanide, methanol, ethylene glycol, acetaminophen (late), cocaine, alcohol. |
| Type B3 Inborn errors | Genetic mitochondrial or enzyme defects. | Mitochondrial disorders (MELAS), pyruvate dehydrogenase deficiency, G6PD-related defects. |
Osmolar gap = measured osm − (2×Na + glu/18 + BUN/2.8). Normal < 10. The trap: the gap shrinks as the parent alcohol is metabolized to its toxic acid, so a late presentation can show a wide AG with a deceptively normal osmolar gap. Order both early and trend.
| Toxin | Source | Toxic metabolite | Bedside clue | Treatment |
|---|---|---|---|---|
| Ethylene glycol | Antifreeze, brake fluid | Glycolic acid (AG ↑) then oxalic acid (calcium oxalate → AKI) | Calcium oxalate crystalluria, hypocalcemia (Ca binds oxalate), AKI, Wood's lamp fluorescence (some products contain fluorescein) | Fomepizole 15 mg/kg IV load → 10 mg/kg q12h. Hemodialysis if pH < 7.25, AKI, end-organ damage, or level > 50 mg/dL. |
| Methanol | Windshield washer, moonshine, industrial solvents | Formic acid (AG ↑, inhibits cytochrome oxidase) | Visual changes (snowstorm vision, optic disc edema, blindness), abdominal pain, putaminal hemorrhage on imaging | Fomepizole + emergent dialysis (lower threshold than EG: pH < 7.30 or any visual changes). Folinic acid 50 mg IV q4h enhances formate clearance. |
| Isopropanol | Rubbing alcohol, hand sanitizer | Acetone (NOT an acid) | Osmolar gap WITHOUT AGMA, ketones positive without acidosis, fruity breath, CNS depression. Mimics DKA but glucose normal. | Supportive only. Fomepizole NOT indicated (no toxic acid metabolite). Dialysis only if hemodynamic instability or coma. |
| Propylene glycol | IV solvent in lorazepam, phenobarbital, diazepam infusions | Lactic acid (Type B lactic acidosis) | ICU patient on prolonged benzo drip with rising lactate without hypoperfusion. AKI possible. | Stop the offending infusion. Fomepizole if severe. Dialysis for refractory cases. |
Hypoventilation fails to clear CO2. Acute (HCO3 rises 1 per 10 mmHg ↑ PaCO2) vs chronic (HCO3 rises 3.5 per 10) distinction matters: chronic is renally compensated, acute is dangerous and may need ventilation.
| Mechanism | Causes | Bedside flag |
|---|---|---|
| CNS depression | Opioids, benzodiazepines, alcohol, barbiturates, brainstem stroke, encephalitis, ICH, post-ictal | Pinpoint pupils + slow RR → naloxone trial. AMS + bradypnea. |
| Lung / airway | Severe COPD/asthma exacerbation (eventual fatigue), end-stage ILD, severe pneumonia, ARDS, pulmonary edema, upper airway obstruction | "Normalizing" PaCO2 in a previously tachypneic asthmatic = pre-arrest. Intubate before the next ABG. |
| Neuromuscular | GBS, myasthenic crisis, ALS, polymyositis, severe hypoK/hypoPhos/hypoMg, organophosphates, botulism, high cervical cord injury | NIF less negative than −20 cmH2O, FVC < 15 mL/kg, paradoxical breathing → intubate before ABG declares failure. |
| Chest wall / restriction | Severe kyphoscoliosis, morbid obesity (OHS), large pleural effusion, flail chest, abdominal compartment syndrome, tense ascites | Restrictive PFT pattern, low ERV. OHS often missed on the ward. |
| Iatrogenic | Permissive hypercapnia (asthma, ARDS protective ventilation), under-set vent rate or tidal volume, sedation oversedation, equipment failure | Check vent settings before treating the patient. Always. |
Hyperventilation. Almost always centrally driven. Most common acid-base disorder in hospitalized patients, and frequently part of a mixed picture (sepsis, salicylates, hepatic encephalopathy).
| Trigger | Mechanism / Notes |
|---|---|
| Hypoxemia | Carotid body drives ventilation. PE, pneumonia, pulmonary edema, high altitude, severe anemia. Always check SpO2 and consider CTPA in unexplained tachypnea. |
| Sepsis | Cytokine-mediated central drive. Often the earliest acid-base abnormality, before lactate or hypotension appear. |
| Pain / anxiety | Voluntary or involuntary hyperventilation. Pure psychogenic hyperventilation is a diagnosis of exclusion (rule out PE, sepsis, ASA first). |
| Salicylate toxicity | Direct medullary stimulation + uncoupling of oxidative phosphorylation. Classic mixed AGMA + respiratory alkalosis. Tinnitus is the giveaway. |
| Hepatic encephalopathy / cirrhosis | Ammonia and progesterone-like metabolites stimulate the medullary center. Almost universal in advanced cirrhosis. |
| Pregnancy | Progesterone is a respiratory stimulant. Normal pregnant PaCO2 is 28–32 with compensatory low HCO3 (~18–20). |
| CNS lesions | Brainstem stroke, tumor, infection, head injury → central neurogenic hyperventilation. |
| Iatrogenic | Over-ventilation on the vent (rate or tidal volume too high). Re-check settings before treating. |
| Drug | Dose | Route | Notes |
|---|---|---|---|
| NaHCOโ | 50-150 mEq | IV | Only pH < 6.9. Monitor Kโบ. BICAR-ICU, Jaber 2018 |
| Fomepizole | 15 mg/kg load | IV | Toxic alcohols |
| Acetazolamide | 250 mg q6-12h | IV/PO | Refractory met alkalosis |
| KCl | 20-40 mEq q2-4h | IV | Must correct Kโบ to fix met alkalosis |
Patient: 58M with septic shock from pneumonia. ABG: pH 7.22, pCOโ 30, HCOโ 12. Na 142, Cl 98, albumin 2.0. Lactate 8.4. Also receiving NS resuscitation for 24h.
Key findings: Step 1: acidemia. Step 2: low HCOโ = metabolic acidosis. Step 3: Winter's: expected pCOโ = 1.5(12)+8 = 26 ยฑ 2. Actual 30 โ pCOโ HIGHER than expected โ concurrent respiratory acidosis (tiring out?). Step 4: corrected AG = (142-98-12) + 2.5(4-2) = 32+5 = 37 โ AG metabolic acidosis. Step 5: delta-delta = (37-12)/(24-12) = 25/12 = 2.1 โ hidden metabolic alkalosis (from vomiting? contraction?).
Management:
Teaching point: A "normal" pCOโ in a septic patient is alarming, they should be hyperventilating. A pCOโ that is higher than Winter's predicted suggests respiratory muscle fatigue and impending respiratory arrest. This is a pre-intubation sign.
Patient: 45F with chronic diarrhea from Crohn's disease. pH 7.30, pCOโ 28, HCOโ 14. Na 138, Cl 112, AG 12 (normal). Urine: Na 30, K 20, Cl 60.
Key findings: Normal AG + metabolic acidosis = NAGMA (non-anion gap metabolic acidosis). Hyperchloremic (Cl elevated). Use urine anion gap (UAG) to distinguish GI vs renal cause: UAG = Na+K-Cl = 30+20-60 = -10 (NEGATIVE).
Management:
Teaching point: The urine anion gap is the key to NAGMA workup. Negative UAG = GI loss (diarrhea, kidneys working fine). Positive UAG = renal problem (RTA, kidneys can't excrete acid). Remember: "Negative = Normal kidneys, Positive = Problem in kidney."
Patient: 72F with COPD on chronic steroids, admitted for COPD exacerbation with NG tube on suction ร 3 days. ABG: pH 7.58, pCOโ 32, HCOโ 38. Kโบ 2.8, Cl 88.
Key findings: Severely alkalemic (pH 7.58, dangerous). Two alkalosis disorders: metabolic alkalosis (HCOโ 38, from NG suction losing HCl + volume contraction) AND respiratory alkalosis (pCOโ 32, should be 48-52 for this HCOโ level as compensation, but is much lower โ concurrent respiratory alkalosis from anxiety/pain).
Management:
Teaching point: Metabolic alkalosis is maintained by three things: volume depletion (kidneys reabsorb Na with HCOโ), hypokalemia (kidneys excrete Hโบ instead of Kโบ), and chloride depletion. Fixing all three (NS + KCl) corrects "chloride-responsive" alkalosis. Urine Cl < 20 = chloride-responsive.